Edition:
United States

Profile: Hikma Pharmaceuticals PLC (HIK.L)

HIK.L on London Stock Exchange

1,665.00GBp
25 May 2017
Change (% chg)

-- (--)
Prev Close
1,665.00
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
818,480
52-wk High
2,703.00
52-wk Low
1,573.00

Hikma Pharmaceuticals Plc is a pharmaceutical company. The Company is focused on developing, manufacturing and marketing a range of both branded and non-branded generic and in-licensed products. The Company's segments include Branded, Injectables, Generics and Others. It sells branded generics and in-licensed patented products across the Middle East and North Africa (MENA) region and other markets. The Company sells specialized generic injectable products across the globe. It also sells non-injectable generic products in the United States, supplying over 260 products in approximately 110 different dosage strengths and forms. The Company's other businesses comprise Arab Medical Containers, a manufacturer of plastic specialized medicinal sterile containers, International Pharmaceuticals Research Centre, which conducts bio-equivalency studies, and the active pharmaceutical ingredient (API) manufacturing division of Hikma Pharmaceuticals Limited Jordan.

Company Address

Hikma Pharmaceuticals PLC

13 Hanover Square
LONDON     W1S 1HL
P: +4420.73992760
F: +4420.73992761

Company Web Links